Supplementary Table 1 from Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma
Year: 2026
Type: supplementary-materials
Abstract: Table S1. Armors chosen for screening based on potential for macrophage reprogramming.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7172443359
